Specifically, they found extensive mutations in the NF1, FGFR3, MBN1, ATRX, KDMGA, PARK2, and PBRM1 genes in the CBPB, which were not observed in the primary adenocarcinoma.73 The gene discussed is FGFR3; the disease is adenocarcinoma.